Abstract
Nitric oxide (NO) plays a very important role in human blood system. In this work, a novel approach has been developed for the quantitation of ultra-trace NO derivatized with 1,3,5,7-tetramethyl-8-(3′,4′-diaminophenyl)-difluoroboradiaza- s- indacene (DAMBO) using a polymer monolith microextraction (PMME) with a poly(methacrylic acid-ethylene glycol dimethacrylate) (MAA-EGDMA) monolith in conjunction with high-performance liquid chromatography (HPLC). Both derivatization and PMME conditions have been optimized in detail. The detection limit of derivatized NO was 2 × 10 −12 mol L −1 (signal to noise = 3) and linear range was 9 × 10 −11–4.5 × 10 −8 mol L −1. The proposed DAMBO-based derivatization-PMME–HPLC-fluorescence detection method has been successfully applied for the determination of NO in 10 μL blood samples of healthy persons and patients suffering from ischemic cardio-cerebrovascular diseases with recoveries varying from 87.40 to 91.60%.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
